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Psychological Factors Relevant to the Prehospital and In-hospital 
Phases of Acute Myocardial Infarction 
Lori W. Kenyon, PhD,* Mark W. Ketterer, PhD,* and Richard C. Preisman, MD* 
Recognition and treatment of psychological factors relevant to the acute prehospital and in-hospital 
phases of myocardial infarction (Ml) are reviewed. Various emotions and personality characteristics 
can be both risk factors for and consequences of acute Ml. Components trf the Type A behavior pattern 
and levels of somatic and emotional awareness have been linked with excessive treatment-seeking 
delay for Ml patients. Psychiatric condhions such as panic disorder may mimic symptomatic 
presentation trf Ml and therefore have implications for differential diagnosis in the emergency room. 
Additionally. anxiety, depression, and neurobehavioral disorders such as delirium are relatively 
common during the hosphalization period and may contribute to potentially lethal CompUcations of 
Ml. Because psychological factors are associated with prognosis during each phase of Ml. the 
identiftcation and treatment of such factors are crucial in providing comprehensive care for MI 
patients. (Heniy Ford Hosp Med J 1991:39:176-83) 
A n interplay between the mind and the heart has been rec-ognized since 1628, with William Harvey's statement (1), 
"Every affection of the mind that is attended with either pain or 
pleasure, hope or fear, is the cause of an agitation whose influ-
ence extends to the heart." Subsequent evidence has accumu-
lated indicating that various emotions appear to serve both as 
risk factors for and consequences of heart disease. This is per-
haps most apparent in the case of acute myocardial infarction 
(MI). As described by Johnston (2), prior research has suggested 
that MI is more likely to occur in persons who are aggressive 
and over-busy or depressed (3), phobic (4), or have poor social 
support (5,6). Furthermore, emotional distress has been demon-
strated to be a frequent consequence of M I , as a heart attack is a 
profound event which presents potential psychiatric as well as 
physiologic morbidity. 
Prehospital Phase: Psychological Factors 
AfTecting Treatment-Seeking Behavior 
Survival in the acute phase of MI and the subsequent progno-
sis are critically dependent upon the early application of medical 
interventions, particularly thrombolytic and other reperfusion 
therapies. The effectiveness of these therapies is limited by the 
elapse of time from symptom onset to the patient's arrival at the 
hospital. Most ofthis total delay time appears to be the length of 
time it takes for patients to decide they are i l l and to seek medi-
cal attention (7-11). Prior studies have had difficulty identifying 
significant factors that explain pafients' delay in responding to 
M I symptoms. The majority of investigations have concluded 
that neither demographic nor medical history variables such as 
age, socioeconomic status, sex, or prior M I reliably predict de-
lay time. Though few studies have examined psychological fac-
tors related to this delay, the following variables have been im-
plicated as affecting delay time: Type A behavior pattem, de-
nial, and somatic and emotional awareness. 
Type A behavior 
Hackett and Cassem (12) suggested that the tendency to deny 
negative features of experience may delay Type A individuals 
from seeking medical help for early symptoms of coronary heart 
disease (CHD). Greene and others (13) inferred from clinical 
observations that Type A persons prefer to avoid reporting early 
heart attack symptoms rather than face the prospect of being a 
patient and not being able to work. In 1983, Matthews and asso-
ciates (9) examined Type A behavior, assessed by the Structured 
Interview, and its relation to illness decisions by M I patients. 
They found that those patients who delayed in the early phase of 
treatment-seeking (time between symptom onset and illness de-
cision) characteristically displayed elevated anger levels, a com-
ponent factor of Type A behavior. Once patients had recognized 
they were i l l . Type B behavior was associated with a longer de-
lay in seeking medical attention. It was unclear whether the gen-
eral Type A behavior pattem was significantly correlated with 
the total delay interval—fime from symptom onset to decision 
to seek medical treatment. Two other recent studies (11,14) 
found no significant relationship between Type A behavior and 
treatment-seeking delay for M I patients. In 1991, Nolan and 
Wielgosz (15) expanded the notion of the Type A behavior pat-
tem to include concepts of adaptive versus maladaptive coping 
styles, judged by the Structured Interview. They investigated 
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MI patients' self-management of cardiac symptoms, including 
delay in deciding to seek treatment, as related to general coping 
behaviors. Results indicated that patients characterized as mal-
adaptive copers, defined by elevated scores on Type A behavior 
and its components, demonstrated greater use of distraction and 
individual-based relief-seeking behaviors for MI symptoms, 
which appeared to put them at risk of increased delays prior to 
deciding to seek treatment for MI symptoms. The authors con-
cluded that there is a need to caution MI patients against over-
utilizing distraction and relief-seeking behaviors, as they may 
inierfere with the patient's ability to identify and quickly re-
spond to symptoms of acute cardiovascular disease. 
Denial 
Although il is generally believed lhal all patients in the acute 
stages of MI deny to some extent that they are experiencing a 
heart attack (16), the role of denial in effecting decisions to seek 
treatment has not been assessed thoroughly. Two prior studies 
have failed to observe significant relationships between denial 
and decision time (11.17). As Wielgosz and colleagues (11) dis-
cussed, an important limitation to the study of denial has been 
the lack of an appropriate psychometric instrument. It may be 
that a major component of denial in cardiovascular disease is a 
reduced awareness of bodily and/or emotional sensations. 
Somatic and emotional nonawareness 
Kenyon and associates (14) recentiy discovered evidence that 
reduced awareness of bodily sensations and emotions (emotional 
nonawareness = "alexithymia") powerfully predicted treatment-
seeking delay for MI patients. Factors affecting time between 
symptom onset and hospital arrival for 103 MI patients admitted 
to Henry Ford Hospital were examined. Though neither demo-
graphic nor medical history variables were significantiy associ-
ated with delay time, patients better able to identtfy emotions 
and/or bodily sensations sought treatment significantly earlier 
than patients with low emotional and/or somatic awareness (low 
emotional awareness median delay = 12.8 hours; high emo-
tional awareness median delay = 3.8 hours; low somatic aware-
ness median delay = 7 hours; high somatic awareness median 
delay = 4 hours). Whether or not patients believed they were 
having a heart attack as well as the perceived salience of symp-
toms also were powerful correlates of treatment-seeking de-
lay and appeared to mediate the relationship between somatic 
awareness and delay time. However, emotional nonawareness 
remained significantly associated with delay time even with 
these two variables controlled. Patients with low somatic aware-
ness appeared less likely to believe they were having a heart at-
tack and reported less salient symptoms and therefore were less 
likely to seek medical attention promptiy. However, even with 
these two intra-event factors considered, emotional nonaware-
ness remained a powerful predictor of delay time. 
A related investigation (18) examining silent versus symp-
tomatic ischemia found that patients with evidence of silent 
ischemia on thallium stress testing were less aware of cardiac 
and other bodily sensations and were less avoidant of harm and 
pain in general than patients with symptomatic ischemia. 
From a pragmatic clinical standpoint, perhaps the most im-
portant aspect of these findings is that information on levels of 
somatic and emotional awareness is premorbidly available. As-
sessment of these characteristics in patients with coronary risk 
factors could allow early identification and appropriate inter-
ventions for persons at risk of excessive delay in responding to 
symptoms of MI. 
Differential Diagnosis in the Emergency Room 
Cardiac disease may mimic psychiatric disorder and vice 
versa. As noted by Vitaliano and associates (19), differentiating 
chest pain caused by CHD and other organic etiologies from that 
associated with a psychiatric disorder is often difficult. For exam-
ple, panic attacks and cardiac arrhythmias or MI share many of 
the same symptoms, such as dyspnea, palpitafions, light-head-
edness, and autonomic arousal (20). Further complicating dif-
ferential diagnosis, emotional stressors can serve to trigger both 
panic attacks and arrhythmias or sudden cardiac death (21; re-
viewed by Frank and Smith [22]), and certain cardiac medica-
tions—beta-blockers, for example—may diminish panic symp-
toms as well as symptoms stemming from cardiac disease. 
In addition to diagnostic testing to mle out organic disease, a 
correct diagnosis can be facilitated by a detailed history of 
symptoms (20). For example, while syncope is common in se-
vere arrhythmias, it is uncommon in panic attacks. Arrhythmias 
also tend to vary in duration from seconds to days, whereas the 
course of panic attacks is more typical, usually lasting between 
5 to 20 minutes (20). While a family history of anxiety disorder 
increases the likelihood of panic attacks in the patient, it does 
not preclude the presence of CHD. 
Cardiac disease and somatoform disorders (e.g., psychogenic 
pain disorder, somatization disorder) are at times mistaken for 
each other but also frequentiy coexist (20). Emotions are fre-
quently somaticized into chest pain, both in patients with and 
without significant heart disease (23). Mayou (24) described 
that atypical or noncardiac chest pain is frequently seen in pa-
tients in medical outpatient clinics, emergency rooms (25,26), 
and cardiac care units (CCUs) (27,28). Persons presenting with 
chest pain without identifiable organic pathology are often anx-
ious and/or depressed (29-31). Such patients appear to contrib-
ute to the 10% to 30% of patients found to have no or nominal 
occlusions on cardiac catheterization (19). In fact, 33% to 46% 
of patients with normal coronary arteries on angiogram display 
panic disorder (23,29,32). Although follow-up studies of pa-
tients with chest pain but normal angiograms have consistently 
indicated a good physical outcome (33,34), many patients report 
persistent chest pain, emotional distress, impairment of social 
and occupational activities, and ongoing use of cardiac and 
other medical resources (35). Although the cause of disability in 
patients with normal coronary arteries is not entirely clear, a re-
cent study indicated that patients with normal angiograms who 
also have panic disorder are more disabled than those without 
panic disorder (36). 
Because of the emotional distress and disability in patients 
with atypical chest pain, as well as the financial aspects of con-
tinuing use of medical services, it is important that effective 
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treatment strategies for these patients be identified and utilized. 
There is encouraging evidence that interventions directed to-
ward associated psychological problems can result in improve-
ment of mood, relief of chest pain, and decreased limitations of 
daily living (24,37-40). 
Mention should also be made of the interrelation between 
substance use disorders, specifically cocaine use, and MI. As 
discussed by Tokarski and colleagues (41), the most prominent 
adverse reaction secondary to cocaine use is MI occurring in 
otherwise healthy, young individuals. Approximately 58 cases 
of acute MI temporally related to cocaine ingestion have been 
reported to date in the English-language literature (42). These 
persons were characteristically young, male, chronic users of 
cocaine, and without any antecedent cardiac history. 
As cocaine use has escalated, the frequency of emergency 
room visits by cocaine abusers complaining of chest pain after 
cocaine use has also increased (41). Such patients who have 
ECG evidence of myocardial injury are easily identified. How-
ever, a more difficult diagnostic and treatment planning di-
lemma is presented by patients who complain of chest pain but 
have a normal or nondiagnostic ECG. In 1990, Tokarski and 
others (41) found evidence, based on creafine kinase (CK) and 
CK isoenzymes, of acute myocardial cellular injury in cocaine 
abusers complaining of chest pain, even though ECGs were nor-
mal or nondiagnosfic. As the researchers recommended, more 
research is needed to determine the significance of such findings 
for long-term prognosis, as a cocaine-induced cardiomyopathy 
may be a potenfial long-term consequence (41). 
Emotional and Neuropsychiatric Sequelae 
in the Hospitalization Period 
MI is a profound psychological event. Patients' beliefs re-
garding impending death and real or imagined losses can and 
should change most of their lives forever. For some patients, 
these changes actually enrich or improve life. However, for 
many others these changes diminish the quality of life, leading 
potentially to physical incapacity, sexual difficulfies, financial 
insecurity, and confiicts in familial role. 
The most obvious and immediate reacfion to MI is anxiety. 
Fear of disability and death is a common source of anxiety. Ad-
ditional causes include nervousness associated with CCU pro-
cedures or events such as codes, ward rounds (43), or transfer to 
a general hospital floor. Explanations regarding the nature of 
these events and reassurance can help to minimize these con-
cems. In addition to emotional sources of anxiety, it is important 
to mle out potenfial organic causes of anxiety in MI patients 
(Table). Furthermore, because 20% of the general population 
have preexisting mental disorders (44), MI patients may come to 
the CCU with a premorbid anxiety disorder. 
Anxiety in MI patients can be manifested in a variety of ways. 
Some patients are overtly vigilant and distressed and may expe-
rience a sense of dread or foreboding. Objective indicators of 
anxiety in-hospital may include tachycardia, tachypnea, diapho-
resis, insomnia, hypertension, and ventricular ectopy (43). 
Other patients may overtly appear to be quietly watchful, sur-
prisingly calm, or unconcerned about the implications of their 
Table 
Organic Conditions Generating Anxiety Symptoms 
in Myocardial Infarction Patients 
• Medication side effects 
Antiarrhythmics 
Digitalis 
Anticholinergics 
Bronchodilators 
Stimulants 
• Withdrawal from sedatives, hypnotics, opiates 
• Electrolyte abnormalities 
Diuretic therapy 
Kidney dysfunction 
• Endocrine disorders 
Thyroid disease 
• Hypoglycemia, hyperglycemia 
• Hypocalcemia, hypercalcemia 
• Pulmonary embolism 
• Central nervous system dysfunction 
Acute embolic stroke 
Hypoxia 
Early delirium 
Atypical seizures 
• Pain 
condition. The latter are referred to as engaging in "denial." De-
nial can refer to lack of appropriate concem over one's medical 
status or a lack of belief in the gravity of the diagnosis. Extreme 
cases have been observed in which patients at discharge deny 
having had a MI despite ECG and enzyme confirmation of the 
diagnosis. This belief may be driven by anxiety over the impli-
cations of the diagnosis or caused by personality characteristics 
such as suspiciousness or mistmsL 
Patients who engage in denial present a dilemma. The fear 
imposed upon a patient by a MI initiates what should be the start 
of reorientation of priorities and restmcturing of life-style. Yet 
the absence of anxiety probably has short-term benefits. Studies 
of denial in medical populations indicate that such patients have 
shorter hospital stays and fewer complications while in the hos-
pital. Yet the same patients have poorer long-term prognoses, 
presumably because of inadequate compliance or concem over 
controlling risk factors (45). 
Monitoring of emotional state is rarely done systematically in 
the CCU. Overt distress is typically noted by nursing staff and 
will often lead to discussion and/or pharmacological treatment. 
Some patients may remain quietiy distressed out of fear of ac-
knowledging their anxiety because doing so may lead to a tem-
porary increase in subjective intensity and/or staff intrusions. 
Others may be unaware of their distress because of severely re-
stricted attentional focus (46) or difficulties in identifying and 
describing their emofions accurately (47). Thus, monitoring of 
the patient's emotional state should encompass both the pa-
tient's subjective report and his or her nonverbal behavior. Rest-
lessness, distractibility, tenseness, hypervigilance, frequent or 
easily initiated startle responses, tics, insomnia, irritability, non-
compliance, and frequent complaining over minor matters all 
can be indications of anxiety. Fluctuating cardiac parameters 
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that cannot be accounted for by other factors may also be indi-
cators of anxiety. 
Estimates of the prevalence of depression in various cardiac 
populations average about 30% or four to five times that seen in 
the general population (48,49). Reactive causes include grief 
and loss of self-esteem related to fears of disability and loss of 
potency secondary to the Ml. Recent work has indicated that 
some of the observed dysphoria occurs premorbidly and may be 
a risk factor for acute ischemic events (50-58). Additionally, de-
pressed mood may represent a major depressive disorder (55) or 
a dysthymic disorder caused by a combination of life circum-
stances and personality characteristics such as being an exces-
sive worrier, hyperconscientious, and/or unreasonably responsi-
ble (52,57). 
Impact on cardiac morbidity and mortality 
Emotional reactions in the emergency room and CCU are im-
portant in and of themselves. Moreover the emotional distress 
associated with Ml may be partially responsible for potentially 
lethal complications of MI, such as cardiogenic shock and ar-
rhythmia (43). Recent prospective studies have raised the ques-
tion of "psychopathogenesis": Does the acutely anxious patient 
have a worse prognosis? The studies on denial might be taken 
to imply that they do. Prior to the advent of beta-blockers and 
thrombolytics, the benefit of CCU admission for MI patients 
was questioned by some (59) and may at fimes have been delete-
rious (60,61). Such studies raised questions about "psychologi-
cal toxicity" of the CCU. The highly technical environment, in-
tensive staff observation, episodic codes, and disruption of nor-
mal sleep pattems probably foster anxiety in some patients. Do 
such emotional states contribute to the biology of ischemic heart 
disease? The psychopathogenesis of ischemic CHD is under ac-
tive investigation (22,62,63). 
Indirect behaviorally-mediated mechanisms, such as increased 
smoking or caffeine use, may explain part of the relationship be-
tween emotional stress and Ml (64,65). However, to date, these 
mechanisms have not been able to account fully for the results of 
epidemiologic studies. The residual relationship of stress to the 
pathogenesis of MI may be accounted for by emotional influ-
ences on neural and neuroendocrine activity. For example, cat-
echolamine release during acute and/or chronic emotional dis-
tress (66,67) may increase platelet aggregation (68-72). Acute 
changes in such thrombotic factors as platelet Factor IV, [3-
thromboglobulin, von Willebrand factor, fibrinopeptide-A, and 
thromboxane (3, have been observed in response to experimen-
tal or natural stressors (73-77). Type A individuals, who are 
characterized by chronic performance anxiety and irritability, 
have also been observed to have increased platelet aggregability 
(78,79). Acute psychological stressors have also been observed 
to increase ischemia demonstrated by ECG (80-83) and wall 
motion abnormalities demonstrated by echocardiography (84) 
or thallium imaging (85). Stress-prone personality characteris-
tics also seem to be correlates of increased ischemia (86) and 
general coronary artery disease (87). Such effects may be cat-
echolamine or serotonin mediated (88-90). Furthermore, ven-
tricular arrhythmias appear to be influenced by heightened emo-
tional arousal (91,92), and personality characteristics or psycho-
social stressors appear related to arrhythmias. A variety of per-
sonality, emotional, and social factors have been associated 
with ventricular premature beats, ectopic beats, lengthening or 
shortening of the QT interval, and/or ventricular tachycardia 
(93-96). Unfortunately, such studies to date have not controlled 
for associated behavioral mechanisms, such as concomitant ele-
vated caffeine use (65,97). 
Management of acute emotional arousal during MI 
Many of the signs and symptoms of emotional distress are 
mediated by the cardiovascular system and accompanied by in-
creased activity of the sympathetic nervous system (43). Espe-
cially because of the already vulnerable myocardium of the MI 
patient, emotional distress, if left untreated, may enhance the 
risk of potentially lethal complications of MI. Thus, the recogni-
tion and treatment of psychiatric complications of MI is critical. 
As alluded to previously, once anxiety has been identified, or-
ganic sources of the symptoms should first be ruled out. The 
possibility of preexisting anxiety disorders should also be ex-
plored, and continuation of preadmission psychotropics should 
be maintained unless there are medical contraindications. Some 
manifestations of anxiety in the CCU may be attenuated by p-
blockade, narcotic use, and informal interactions between pa-
tients and .staff. Reassurance by staff is accomplished in several 
ways. Some patients are reassured merely by being under obser-
vation and are able to entmst themselves to the system while 
others require frequent or repetitious explanations of the events 
taking place around them. Conversely, some patients wish to 
know few details of their care. In such cases, it is best to leave 
them to their own coping style as long as their care is going well. 
Because beliefs regarding the Ml are major determinants of car-
diac invalidism (98), it is important that MI patients receive de-
tailed explanations of what to expect regarding physical recov-
ery. Specific areas of importance include work schedules, sex-
ual activity, and cardiac rehabilitation (43). 
At one time it was common to provide MI patients with cen-
tral nervous system (CNS) depressants such as phenobarbital or 
Valium. With more recent advances in acute care, such practices 
appear to have become less common, and benzodiazepines have 
replaced barbiturates as drugs of choice for treatment of anxiety 
(43). However, randomly assigned, placebo-controlled clinical 
trials of benzodiazepine use by MI patients are lacking. None-
theless, prudent judicious use of such medications seems war-
ranted. Benzodiazepines are known to be effecttve at alleviating 
transitory anxiety and may decrease platelet aggregation (99, 
100). Given the circumstances operative in the emergency room 
and CCU, routine use of a scheduled, as opposed to as neces-
sary, benzodiazepine should be considered. Absolute contrain-
dications include sleep apnea (101,102) and respiratory insuffi-
ciency. Relative contraindications might include a history of 
substance abuse, although the benefits might well outweigh the 
risks for such individuals. 
After a diagnosis of depression has been confirmed, organic 
causes should be ruled out. As discussed by Stern (43), the 
work-up should include screening of electrolytes, calcium, and 
magnesium and thyroid function tests. Medications frequentiy 
used in cardiac patients which may have depressant properties 
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include some antihypertensives and beta-blockers, especially 
propranolol. Assuming that organic causes have been ruled out, 
depression is best treated during the first days to weeks afler 
a Ml by reassurance, emotional support, and early ambulation/ 
rehabilitation. Tricyclic anfidepressants, because of their im-
pact on conduction and other anticholinergic effects, are best 
avoided until the myocardium is well healed and the PR and QT 
intervals have retumed to normal. Where depression is severe, 
unresponsive to psychological treatment, and/or presents a dan-
ger in which treatment cannot be delayed by several weeks, non-
traditional pharmacological agents such as alprazolam and even 
psychostimulants (dextroamphetamine and methylphenidate) 
have been used with relative safety in acute cardiac settings (43). 
Pharmacological treatment of the cardiovascular components 
of anxiety may be insufficient to control all of the associat-
ed risks (103,104). Psychological techniques provide another 
means of controlling anxiety and have the added advantages of 
providing the patient with methods of increasing self-control 
and potentially long-term risk modification. Techniques used in 
alleviating acute anxiety include distraction, relaxafion, educa-
tion, support, and cognifive therapy. Distracfion might involve 
nothing more than a radio or television to capture the patient's 
attention and thus reduce ruminative preoccupation with every 
passing chest sensafion or the meaning of every word spoken by 
staffi Relaxafion training may be difficult in the hectic CCU en-
vironment but provides patients with skills to calm themselves 
and restore some sense of personal control over events. The 
transient effects of emotion on sympathetic arousal are well doc-
umented (66,67), and relaxation is also well documented at re-
versing such effects (105). Cognitive therapy aimed at identify-
ing and modifying the patient's erroneous beliefs can be greatly 
helpful to some patients. Psychological interventions with MI 
patients have been reported to alleviate emotional distress, re-
duce the length of hospitalization and subsequent use of medical 
services, and decrease the occurrence of congestive heart failure 
and arrhythmia (106-108). 
Neurobehavioral Difficulties in MI Patients 
Because of the association of advancing age both with cardiac 
disease and with cognitive impairment (109), disturbed behav-
ior and its neurological implications can be important issues 
in the management of MI. These disturbances of brain function 
are among the most frequent syndromes seen in the hospital 
(110) and in clinical care in general (111). Approximately 3% of 
Americans age 55 or older have severe cognitive impairment, 
and an additional 10% have mild cognitive impairment (109). 
This latter figure suggests that a significant number of patients 
suffering a MI potentially have difficulty understanding, re-
membering, and complying with medical explanafions and rec-
ommendations. They may have additional behavioral difficul-
ties undergoing treatment and rehabilitation. Therefore, recog-
nition and appropriate management of such disorders is clini-
cally important. 
Neurobehavioral disorders can be diagnosed with relative 
ease at the bedside, especially those where global impairment of 
cognition is present. Globally impaired cognition is classified 
either as dementia or delirium. Four signs are essential for the 
diagnosis of global impairment, although other behavioral fea-
tures are frequently present. Disorders of orientation, recent 
memory, and intellectual capacity and inability to sustain atten-
tion and wakefulness are cardinal diagnostic features of global 
cognitive impairment. A patient who is able to sustain attention 
and wakefulness but has the other three features noted above is 
usually demented. If wakefulness and attention are impaired in 
addition, delirium is usual. Other behavioral features, such as 
mood disturbance, hallucinations, paranoia, agitation, or leth-
argy, are frequently present but are unnecessary or insufficient 
for diagnosis. These problems are most important for manage-
ment, however, and may appear to be the most obvious behav-
ioral features on initial examination. 
Differentiation of dementia from delirium is important for 
several reasons. Although dementia will often present with man-
agement problems, urgency of work-up is usually not an issue. 
Delirium, however, implies a need for urgent evaluation be-
cause a substantial mortality risk is correlated with this syn-
drome (109). The etiology of delirium is either toxic, metabolic, 
infective, seizure-related, or due to structural problems in the 
CNS. Delirium has been reported to occur in 2% to 12% of CCU 
patients (112,113). Stem (43) discussed common causes of de-
lirium in the cardiac patient population to include: CNS com-
promise secondary to cardiac arrest, anemia, hypoxia, low car-
diac output, and dmg toxicity. Many cardiac medications are as-
sociated with delirium (20,114,115). For example, antiarrhyth-
mic medications, digitalis preparations, aminophylline prepara-
tions, some antihypertensives, and occasionally beta-blockers 
can be problematic. Posttransplantafion recipients (116) and 
postcardiotomy patients (117) also are at risk for delirium. 
Psychopharmacology plays a role in the management of both 
demenfia and delirium, but the underlying etiology must be 
sought if prolonged improvement in delirium is to be gained. 
While the search for the cause of the delirium is in progress, an-
tipsychotic medication (e.g., haloperidol, 0.5 to 5.0 mg daily) 
often will ameliorate psychotic symptoms associated with these 
syndromes. Protective restraint is also frequently necessary to 
prevent patients from unintentionally harming themselves or 
others (e.g., falls, removing catheters or arterial lines). If delir-
ium is caused by withdrawal of CNS depressants (e.g., alcohol, 
barbiturates), the most appropriate treatment involves reintoxi-
cating the patient with a cross-tolerant drug (e.g., a benzodiaz-
epine) and then gradually withdrawing the medication. "Dmg 
protocols" (e.g., phenobarbital, lorazepam) are currently being 
used for withdrawal of CNS depressants, but many patients 
require custom-dosing of drugs to undergo safisfactory with-
drawal, as effecfive doses of medication vary substantially from 
person to person. Occasionally, antipsychotic medication is a 
helpful adjunct in withdrawing CNS depressant dmgs. 
Conclusions 
The disability associated with Ml has psychiatric as well as 
physiologic manifestations. Furthermore, psychological factors 
are strongly associated with prognosis during each phase of MI, 
from the prehospital through the convalescent periods, and in 
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many cases enhance morbidity and mortality for infarction pa-
tients. Therefore, the identificafion and treatment of such factors 
are cmcial in providing comprehensive care for MI patients. 
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